Intuitive Surgical, Inc.

ISRG
Healthcare diagnosticsRobotics
$379.05vs prev close+0.24(+0.06%)
$328.5752W Range$603.88
18% from low
+41.31 (+12.24%)Past 1M
Price
ARK Trade PatternPREMIUM
1M Trades
-
No trades in 1M
1M net buy
$0
0 shares
Portfolio Weight
0.20%
1M 0.00%p
Holding ETFs
1 ETFs
ARKQ

Buy · Weight Up

ARK net-bought the stock and the price rose, increasing its portfolio weight.

Shares +8.9% · Market value -5.6% · Weight 0.00%p

Trade Intensity
No trades in 1M
Trade Log
DateActionETFSharesCloseEst. total
26.07.17BUYARKQ7,975$345.42$2.8M
26.02.05BUYARKQ11,960$476.32$5.7M
25.12.12BUYARKQ6,212$542.32$3.4M
25.10.20BUYARKQ9,174$458.47$4.2M
25.07.28BUYARKQ4,991$493.95$2.5M
24.09.23SELLARKQ1,078$489.07$527.2K
24.09.20SELLARKQ377$486.20$183.3K
24.09.18SELLARKQ364$482.09$175.5K
24.09.17SELLARKQ228$483.32$110.2K
24.09.09SELLARKQ4,412$479.39$2.1M
24.07.19SELLARKQ3,623$455.01$1.6M
23.11.06BUYARKQ3,186$277.26$883.4K
23.10.20BUYARKQ3,379$266.91$901.9K
23.08.01SELLARKQ14,339$323.95$4.6M
23.05.04SELLARKQ1,374$303.21$416.6K
07.17BUY
7,975
ARKQClose$345.42Est. total$2.8M
02.05BUY
11,960
ARKQClose$476.32Est. total$5.7M
12.12BUY
6,212
ARKQClose$542.32Est. total$3.4M
10.20BUY
9,174
ARKQClose$458.47Est. total$4.2M
07.28BUY
4,991
ARKQClose$493.95Est. total$2.5M
09.23SELL
1,078
ARKQClose$489.07Est. total$527.2K
09.20SELL
377
ARKQClose$486.20Est. total$183.3K
09.18SELL
364
ARKQClose$482.09Est. total$175.5K
09.17SELL
228
ARKQClose$483.32Est. total$110.2K
09.09SELL
4,412
ARKQClose$479.39Est. total$2.1M
07.19SELL
3,623
ARKQClose$455.01Est. total$1.6M
11.06BUY
3,186
ARKQClose$277.26Est. total$883.4K
10.20BUY
3,379
ARKQClose$266.91Est. total$901.9K
08.01SELL
14,339
ARKQClose$323.95Est. total$4.6M
05.04SELL
1,374
ARKQClose$303.21Est. total$416.6K
1 / 2

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline
Institutional Holders
3 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest
LIVE
Shares
67,386
Portfolio Weight
0.2%
in ETF 1.29%
Est. Value
$25M
30D Net
+$3M
Philippe LaffontCoatue Management
Increased
Shares
64,387
Portfolio Weight
1.04%
Est. Value
$36M
vs Prev Quarter
+455% (12K→64K)
Ray DalioBridgewater Associates
Decreased
Shares
11,170
Portfolio Weight
0.02%
Est. Value
$6M
vs Prev Quarter
-8% (12K→11K)

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Analyst recommendation distribution33
Overall Opinion
Buy
Strong Buy
7
Buy
17
Hold
8
Sell
1
Analyst Targets
avg.
$478.01
vs Current +26.2% upside
Current$378.81
Low ~ High$324.00 ~ $685.00
Firm
Position
Price Target
Upside / Downside
Close Price
Action
Date
Oppenheimer
Outperform
$500.00
+31.99%
Upgrade
2026-08-12
HSBC
Hold
$931.00
+145.77%
Downgrade
2026-07-30
Raymond James
Outperform
$483.00
+27.50%
Maintain
2026-07-17
Piper Sandler
Overweight
$470.00
+24.07%
Maintain
2026-07-17
JP Morgan
Overweight
$450.00
+18.79%
Maintain
2026-07-17
1 / 4
Avg Target
$478.01
vs Current +26.2% upside
Buy
33 analysts
Strong Buy 7Buy 17Hold 8Sell 1
Low $324.00
Current $378.81
High $685.00
FirmPositionTargetUpsideCloseActionDate
OppenheimerOutperform$500.00+31.99%Upgrade26.08.12
HSBCHold$931.00+145.77%Downgrade26.07.30
Raymond JamesOutperform$483.00+27.50%Maintain26.07.17
Piper SandlerOverweight$470.00+24.07%Maintain26.07.17
JP MorganOverweight$450.00+18.79%Maintain26.07.17
1 / 4

Price Information

Previous Close$378.81
Open$375.57
Day Range$367.24 - $382.04
52-Week Range$328.57 - $603.88
1-Year Change-19.13%

Trading Volume

Volume2,010,937
Avg Volume (3mo)3,146,475

Valuation

Market Cap135.7B
Book Value$51.34
Shares Outstanding358,278,038

Financials

Revenue (TTM)11.0B
Net Income3.1B
EPS$8.71
EBITDA4.2B

Profitability

P/E Ratio43.49
P/B Ratio7.38
Return on Equity (ROE)17.42%
Return on Assets (ROA)10.51%
Profit Margin28.45%
EV/EBITDA30.79
Beta1.46

Dividend

Dividend Rate-
Dividend Yield-

Technical

RSI(14)51.91
Company Overview

Intuitive Surgical develops and manufactures advanced robotic systems for minimally invasive surgery and diagnostic procedures. Their flagship product, the da Vinci Surgical System, along with the Ion endoluminal system, enables physicians to perform complex procedures with greater precision. The company also offers comprehensive support services and digital tools, positioning itself as a leader in robotic-assisted healthcare.

P/B
7.38
High valuation
ROE
17.4%
Return on Equity
Beta
1.46
Market Volatility
RSI(14)
51.9
Neutral

AI-generated summary. Not investment advice.

Recent News

Mymoneywood cross-analyzes and curates publicly available SEC 13F-HR filing data. We do not provide investment advice and do not recommend buying or selling any specific securities.

Past performance does not guarantee future results. All investment decisions and responsibilities rest with the user.

Terms of Service·Investment Disclaimer·Privacy Policy·Refund Policy

Always summer | biz@mymoneywood.com
© 2026 Always summer. All rights reserved.

Enter your email below to sign up for the newsletter.

By entering your email you agree to our Privacy Policy. You can unsubscribe anytime.